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ABSTRACT
Ruminal Protection and Intestinal Availability of Rumen-Protected Methionine and
Lysine in Lactating Dairy Cows

by

Sara S. Menchu, Master of Science
Utah State University, 2019

Major Professor: Dr. Jeffery O. Hall
Department: Animal, Dairy, and Veterinary Sciences
Rumen protected Methionine (MET) and Lysine (LYS) are critical for milk protein
synthesis in dairy cows. N-acetyl-L-methionine (NALM) is a MET derivative that
consists of L-Met protected with an acetyl group that is attached to the α-amino group.
N-acetyl-L-lysine (NALL) is a LYS derivative that is similarly protected. The objectives
of these studies were to quantify the gastrointestinal availability of NALM and NALL.
Three experiments were run as 3 × 3 Latin square using 3 second lactation Holstein cows
that have been fitted with cannulas in the rumen and duodenum. The cows were fed diets
containing the supplements for two weeks prior to each experiment so that the rumen
microbes had time to adjust to the supplement. Each period consisted of 10 d of
adaptation followed by 2 d of sampling. A dose of 0, 30, or 60 g of NALM was placed
under the rumen mat at the time of feeding every day during experiment 1. The cows
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were similarly supplied with 0, 60, or 120 g of ƐNALL during experiment 2. The cows
were supplemented with 0 g, 120 g of ƐNALL, or 120 g of diNALL during experiment
3. On day one of sampling, a liquid marker (Co-EDTA) was also administered at the
time of the protected AA administration. Blood, ruminal, and duodenal samples were
taken at hours 0, 1, 3, 6, 9, 12, and 24 post-feeding. There were no differences for milk
production, milk protein, milk fat, or DMI for NALM or either NALL. There were no
differences for ruminal escape (69.1% and 46.2% respectively) and duodenal appearance
(2.16% and 3.40% respectively). The ruminal escape of ƐNALL was not different
between the 120 g dose (32.7%) and the 60 g dose (27.2%). Duodenal appearance was
higher (P < 0.01) for the 60 g dose (2.86%) than for the 120 g dose (1.19%) of ƐNALL.
Acetate, propionate, butyrate, and valerate were higher (P < 0.01) for the supplemented
cows during experiment 1 with NALL. There were no differences between ƐNALL and
diNALL for rumen escape, duodenal appearance, VFA production, or blood LYS AUC.
Results of the experiment verify significant protection of the N-acetyl MET and LYS
from rumen degradation.
(77 pages)
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PUBLIC ABSTRACT

Ruminal Protection and Intestinal Availability of Rumen-Protected Methionine and
Lysine in Lactating Dairy Cows
Sara S. Menchu, Master of Science

Rumen protected Methionine (MET) and Lysine (LYS) are critical for milk protein
synthesis in dairy cows. N-acetyl-L-methionine (NALM) is a MET derivative that
consists of L-Met protected with an acetyl group that is attached to the α-amino group.
N-acetyl-L-lysine (NALL) is a LYS derivative that is similarly protected. The objectives
of these studies were to quantify the gastrointestinal availability of NALM and NALL.
Three experiments were run as 3 × 3 Latin square using 3 second lactation Holstein cows
that have been fitted with cannulas in the rumen and duodenum. The cows were fed diets
containing the supplements for two weeks prior to each experiment so that the rumen
microbes had time to adjust to the supplement. Each period consisted of 10 d of
adaptation followed by 2 d of sampling. A dose of 0, 30, or 60 g of NALM was placed
under the rumen mat at the time of feeding every day during experiment 1. The cows
were similarly supplied with 0, 60, or 120 g of ƐNALL during experiment 2. The cows
were supplemented with 0 g, 120 g of ƐNALL, or 120 g of diNALL during experiment
3. On day one of sampling, a liquid marker (Co-EDTA) was also administered at the
time of the protected AA administration. Blood, ruminal, and duodenal samples were
taken at hours 0, 1, 3, 6, 9, 12, and 24 post-feeding. There were no differences for milk

vi
production, milk protein, milk fat, or DMI for NALM or either NALL. There were no
differences for ruminal escape (69.1% and 46.2% respectively) and duodenal appearance
(2.16% and 3.40% respectively). The ruminal escape of ƐNALL was not different
between the 120 g dose (32.7%) and the 60 g dose (27.2%). Duodenal appearance was
higher (P < 0.01) for the 60 g dose (2.86%) than for the 120 g dose (1.19%) of ƐNALL.
Acetate, propionate, butyrate, and valerate were higher (P < 0.01) for the supplemented
cows during experiment 1 with NALL. There were no differences between ƐNALL and
diNALL for rumen escape, duodenal appearance, VFA production, or blood LYS AUC.
Results of the experiment verify significant protection of the N-acetyl MET and LYS
from rumen degradation.
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CHAPTER 1
INTRODUCTION
Protein Metabolism is a complicated process in ruminants. Rumen microbes degrade much
of the protein that is provided in the diet (Giallongo et al., 2016). This means that some protein
is not available for systemic use by the animal. Dairy cows require protein to build enzymes and
build tissue. Protein is also necessary for synthesis of milk proteins. Inadequate dietary protein
makes it impossible for a cow to sustain high milk production (Lee et al., 2015).
Proteins are built using different amino acids (AA). There are AA that cannot be adequately
synthesized by the animal and must therefore be supplied in the diet. These are referred to as
essential AA (EAA) (Schwab et al., 2010). The EAA that are not typically supplied in sufficient
amounts in the diet are said to be limiting. The two most limiting AA in a typical dairy diet are
Lysine (LYS) and Methionine (MET) (Weiss et al., 2002). Simply supplementing diets with
free MET and LYS does not suffice due to the extensive degradation and use of these AA by
rumen microbes (Chalupa et al., 1976. Onodera et al., 1993).
Many methods have evolved over time to protected MET and LYS from rumen
degradation. Some minerals were bound with AA to provide protection. This proved to be
ineffective and costly (Graulet et al., 2005). Lipid coatings were fairly effective at ruminally
protecting MET and LYS, but the amount of AA that was released in the small intestine was
minimal at best (Schwab and Ordway, 2003; Sakkers et al., 2013).
Protecting LYS has proven more difficult than for MET. Methods are frequently less
effective for LYS (Rossi et al., 2003). For this reason, LYS is still most commonly protected
with lipids. Less information is available for LYS than for MET on the effectiveness of
different protection methods (Evans et al., 2015).
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When studied by Rossi et al., (2003), ethyl-cellulose coating also released lower
amounts of MET into the small intestine than had been expected. Various MET analogs
and precursors have been used as well, but often have low bioavailability (Koenig et al.,
1999; Graulet et al., 2005). The protection method that appears to provide the most
bioavailability so far appears to be the pH sensitive polymer (Schwab et al., 2010).
N-acetyl-L-Methionine (NALM) and N-acetyl-L-Lysine (NALL) are both derivatives
that are protected in the rumen by attaching an acetyl group to the α-amino group of the AA.
The acetyl group protects the MET or LYS from microbial degradation by blocking
aminopeptidase from accessing the amino group (Wallace et al., 1993). The acetyl group is
then cleaved from the AA in the small intestine. The released AA should then become
available for absorption (Baxter et al., 2001). The current studies were intended to
determine the ruminal protection and intestinal availability of MET and LYS from NALM
and NALL, respectively.
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CHAPTER 2
REVIEW OF LITERATURE
In the United States, milk is sold under the multiple component pricing system. This means
that milk fat, and milk protein are more valuable to dairy farmers than the liquid portion. Many
methods have been tried in order to increase milk protein yield. Supplementation has thus far
proven to be the most useful. Protein supplements, however, can be expensive and total protein
costs can be up to 80% of feed costs. Therefore, efficient protein utilization is paramount to
maintaining the health and high production of the modern dairy cow while also keeping costs as
low as possible. Increasing protein utilization in ruminants also decreases the amount of
nitrogen that is lost into the environment via urine and manure. This has become more and more
important as environmental concerns are receiving increasing attention. Rumen protected amino
acids (RPAA) have been developed in order to supply the specific amino acids (AA) needed by
the cow in the amounts necessary. Methionine (MET) and Lysine (LYS) are generally accepted
as the most limiting AA when an alfalfa hay and corn silage diet is fed. For this reason,
emphasis has been placed on successfully protecting these two AA from degradation in the
rumen. This literature review will discuss some of the ways that MET and LYS have been
protected, and the ramifications they have on production in dairy cattle.
Protein
Cattle have evolved to utilize diets that were low in digestible protein. The ability to take
plant proteins, as well as other protein building blocks, and turn them into meat and milk is an
advantageous characteristic of ruminants. Because of this, nitrogen efficiency may decrease as
high protein feeds are fed. However, much research is still needed to fully understand the
particulars of protein digestion and use in the ruminant digestive tract (Calsamiglia et al., 2010).
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Protein utilization is an inefficient process in ruminants. Due to fermentation by rumen
microbes, much of the protein that is supplied in the diet is not the protein that is available for the
systemic use of the cow. Only 20-35% of dietary crude protein (CP) will be used in the
production of milk proteins (Giallongo et al., 2016). Many strategies, such as low protein feeds,
supplying limited energy, altering rumen degradable (RDP) and rumen undegradable protein
(RUP) ratios, and protecting amino acids from rumen degradation have been employed to
improve the efficiency of this process. Although microbial fermentation efficiency has
improved, little has been accomplished in overall nitrogen utilization efficiency over the last few
decades (Calsamiglia et al., 2010). However, much has been learned about protein use in the
dairy cow. After parturition, cows begin producing large quantities of milk, which requires a lot
of nutrients. At the same time, dry matter intake (DMI) is low in the days following parturition.
This results in a negative energy balance for cattle. This is especially true for high producing
dairy cows. There is a high demand for high quality protein in the diet during early lactation in
order to both maintain milk protein production and to reduce body weight (BW) loss. Protein
that is consumed by the cow goes to the rumen where microbes break it down into ammonia and
peptides. These are used by bacteria and protozoa for their own growth requirements and
microbial protein synthesis. These microbes will eventually be washed out of the rumen and into
the lower digestive tract. The cow is then able to digest these microbes in the abomasum and
utilize their protein. Most protein that is available to the cow post-ruminally comes in the form
of microbial protein (NRC, 2001). Generally, protein from bacteria and protozoa contains a
good balance of AA. However, the proportions are not consistent. The small intestine also uses
some AA before they can be absorbed into the blood stream (Calsamiglia et al., 2010). This
makes it difficult to determine the amount of AA that the cow is actually absorbing into the
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bloodstream. Knowing the amount of each AA that is delivered to the cow is important because
dairy cows can function on non-protein nitrogen, but high milk production is not sustainable
without the proper balance of AA (Lee et al., 2015).
Crude Protein
Traditionally, diets were formulated based on concentration of CP. There are two main
types of protein within CP. Those consist of protein that can be digested by the rumen microbes
and that which passes through the rumen and may become available directly to the cow. RDP
and RUP must be balanced in order to maintain rumen health and high production. Adequate
RDP-about 10% DM-will be utilized for microbial growth as long as there is sufficient energy
(Weiss et al., 2002). However, feeding an excess of RDP results in large amounts of nitrogen
that cannot be fully utilized by rumen microbes (Weiss et al., 2002). This excess nitrogen is
absorbed into the blood in the form of ammonia. The liver converts the ammonia into urea. The
urea can then be excreted in the urine. Excess urea can build up in the blood and can reach toxic
concentrations. A high concentration of BUN can lead to a decrease in reproductive efficiency
(NRC, 2001). In order to decrease the negative effects that feeding excess CP has on the body
and the environment, many researchers and farmers began putting deficient amounts of CP in the
diet. This also proved to be problematic in terms of productivity. In one study done by
Giallongo et al. (2016), lowering the amount of CP in the diet caused DMI to decrease. A
reduction in DMI can be costly for a dairy because it can negatively affect milk production and
milk protein yield (Giallongo et al., 2016). This is due to the fact that, as previously discussed,
microbes require RDP for growth. Furthermore, RUP is required to maintain high milk
production because this supplies protein for absorption by the cow. In a study by Osorio et al.
(2013), it was found that increasing RUP during the last trimester of gestation increased milk
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production in the following lactation. All of these benefits are lost if CP is lowered too far
below dietary requirements, or if RDP and RUP are not provided in proper proportions. Current
research shows that much more attention should be paid to the amount of AA in the diet rather
than overall CP (Schwab, 2010).
Microbial Protein Synthesis
Microbial protein synthesis (MPS) is important because after the microbes die, they are
digested by the cow. Increasing MPS increases the amount of microbial protein that flows into
the abomasum and is utilized. It simultaneously decreases the amount of excess ammonia-N
present in the rumen as microbes incorporate it into their proteins. Small peptides and AA
supply an important source of nitrogen for microbes. In fact, these take less energy to utilize
than complete proteins (Calsamiglia et al., 2010). The efficiency at which these molecules are
used can be decreased by protozoa that ingest bacteria. Some of this nitrogen can be recovered
by the cow when these microorganisms wash into the abomasum. However, some purines are
not bioavailable, and will therefore be lost. The majority of microbial N is present in the form of
amino acid-N. These can be broken down and used by the cow. Nucleic acid-N cannot be
completely broken down and will be excreted in the urine. (Calsamiglia et al., 2010).
Synchronization
Nitrogen from protein cannot be fully utilized in the rumen unless adequate carbohydrates
are also being fed. Carbohydrates supply the energy required by the rumen microbes to break
down dietary protein and incorporate it into microbial protein (NRC, 2001). If there are not
enough carbohydrates available, the cow must deal with the excess protein. This is costly to the
animal. Energy is spent taking excess protein and converting it into urea so that it can excreted
from the body via the urine (Evans et al., 2015). When sufficient carbohydrates are present,
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microbes in the rumen are able to break dietary protein down to ammonia and peptides. Excess
ammonia is then absorbed through the rumen wall into the blood. From there it can be recycled
or eliminated from the body (Wu et al., 2012).
Fate of Protein
Liver
The AA that are available to the mammary gland are not present in the same amounts that
they were absorbed. This is due to the fact that the liver utilizes some AA. It catabolizes many
proteins and uses many AA for the carbon backbones during glucose synthesis (Calsamiglia et
al., 2010). Methionine may be removed by the liver in large quantities. The liver may oxidize
MET or use it to synthesize export proteins (Vyas et al., 2009).
Mammary gland
Nitrogen utilization in the mammary gland is a complex process. The extent to which AA
are used can vary dramatically. The more AA that are available in the bloodstream, the more
that can be used for protein synthesis in the mammary gland. When there are less AA present,
the body will increase overall blood flow (Calsamiglia et al., 2010). This increase in blood flow
increases the AA that pass through the liver and may increase the AA available for use in the
mammary gland. This is a process that is most effective during early lactation. The epithelial
cells inside the mammary gland also have the ability to increase the percent of AA that are
absorbed when the supply from the bloodstream is low and there are many proteins present in the
mammary gland that 0 g dose the synthesis of proteins once the AA have been absorbed
(Calsamiglia et al., 2010).
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Nitrogen Recycling
Nitrogen recycling is an advantageous characteristic of ruminants. Recycling refers to when
nitrogen is brought back from the blood stream into the rumen, where it can be used by
microbes. The use of this pathway theoretically increases with the decrease of available dietary
nitrogen. Ammonia is absorbed from the rumen and transported to the liver. The ammonia is
converted to urea. Urea may be excreted in the urine. The urea that is present in the blood can
enter back into the rumen through the saliva. It may also be drawn into the rumen from the
blood down the concentration gradient. The urea can then be broken down to ammonia in the
rumen (Reynolds, 1992). Rumen microbes require the presence of ammonia for growth and
microbial protein synthesis. Maintaining adequate concentrations of ammonia can be
energetically expensive for the cow. If little protein is available in the diet, ammonia is more
readily absorbed through the rumen wall. Energy must then be used to recycle nitrogen back
into the rumen. Although nitrogen recycling has proven useful in maintaining the animal in
extreme conditions, this tactic has not been shown to have benefits for high production on
dairies. Reducing the nitrogen in the diet does seem to increase the recycling process, but it does
not upregulate as quickly as the nitrogen intake is limited (Calsamiglia et al., 2010). Therefore,
high milk production cannot be maintained on little protein in a real-world situation (Giallongo
et al., 2016).
Amino Acids
Amino acid concentration can be quite different in the diet depending on the ingredients
used. A diet that is heavy in corn products will typically be low in LYS. Feeding mostly alfalfa
generally limits the amount of MET that is available in the diet (Weiss et al., 2002).
Furthermore, typical plant or animal by-product sources of AA are generally more easily broken
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down and utilized by rumen microbes. This limits the amount of AA that bypass the rumen and
become available to the cow (Koenig et al., 2001).
There are many AA, however only 20 are used to build proteins. Out of these, 10 are
recognized as being necessary in the diet because the cow cannot synthesize them herself. These
are known as essential amino acids (EAA). These EAA are absorbed by the cow from microbial
protein and RUP as well as the cow utilizing them from endogenous proteins. Every time that a
protein is assembled, it requires the same AA. The bonding between these AA, as well as
between side chains, is what gives proteins their shape. These proteins are then utilized in tissue
synthesis as well as their role in many other important functions. Many nitrogen-containing
compounds are made using AA. These include hormones, neurotransmitters, nucleotides for
DNA and RNA, as well as many others (Schwab et al., 2010). Importantly, AA are used to
synthesize tissue and milk proteins. They are also important for growth, maintaining body
weight, and milk production. Amino acids may also be used for gluconeogenesis or fatty acid
synthesis (Lobley et al., 1992). The effects of MET and LYS supplementation are greater in
early lactation when demands for AA are high and available energy is low (Osorio et al., 2013).
Of their many uses, milk protein synthesis uses significant amounts of AA. Mammary cells
remove free AA that are present in the arterial blood and utilize them in the making of milk
protein (Patton et al., 2015). However, mammary cells are not always as efficient as is
necessary.
In fact, as the supply of AA increases, the efficiency at which the body uses these AA
decreases (Vyas et al., 2009). This happens as the metabolic pathways for AA become saturated.
As requirements are reached for the mammary gland, AA may be oxidized by the liver and used
for gluconeogenesis instead of making milk protein. This inefficiency is further compounded by
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the use of AA by gut epithelial cells and by inefficient reabsorption of endogenous sources (Vyas
et al., 2009). In one study by Lee et al. (2015), a negative relationship between supply of AA
and the efficiency at which the AA was used for milk protein synthesis was found to be larger
than expected. When LYS and MET were supplied at 50% of dietary requirement, utilization of
these AA for milk protein synthesis was at 90%. On the other hand, when 125% of dietary
requirement was fed, efficiency of utilization was found to be only 60%. As the percentage of
AA supplied exceeds the needs of the animal, the metabolic pathways become overwhelmed.
The excess AA will be excreted and lost. This decreases the overall efficiency of utilization (Lee
et al., 2015). Even so, meeting the dietary optimum of AA concentration is still important.
When insufficient AA are supplied, cows can only maintain themselves so long before problems
arise. Deficiencies of AA in the diet lead to tissue mobilization (Giallongo et al., 2015). After a
period of time, production will also be negatively affected by inadequate AA in the diet.
Decreased protein or AA can also cause other animal or environmental effects. Decreased
immunity may be seen when dietary AA are insufficient (Giallongo et al., 2016). Supplying a
greater amount of AA to the small intestine for absorption increases the amount of protein
synthesis in the mammary gland. In a study by Ordway et al. (2009), they found that
supplementing MET both prepartum and postpartum seemed to prevent protein loss from body
tissues. This may help maintain health and longevity of the animal. Furthermore, supplementing
MET and LYS improves the concentration of EAA while allowing the overall RUP of the diet
to be reduced (Ordway et al., 2009). This means that less nitrogen will be excreted into the
environment. Thus, the health of the environment can also be maintained. One study by Lee et
al (2015) discovered that ammonia emissions from manure were 31% lower when diets were
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supplemented with MET and diets that were supplemented with LYS and MET showed an
average decrease of 19% in ammonia emissions.
Methionine
Methionine is an AA that is important in many different processes. It is utilized in
synthesizing proteins, but it is also important as a source of methyl groups. Methionine is used
to make cysteine, taurine, creatine, phosphatidylcholine, and carnitine. It also plays an important
role in gene expression because MET is used to methylate cytosine and histone (Bertoli et al.,
2013). According to NRC (2001) recommendations, MET should be supplied 2.4% of
metabolizable protein (MP).
Coating Technology
Free MET and LYS are rapidly degraded by microbes in the rumen (Chalupa et al., 1976.
Onodera et al., 1993). This means that they do not make it to the small intestine where they can
be absorbed. Researchers have spent decades testing many different types of protection methods
to enhance the amount of AA that reaches the small intestine for absorption. Early on, many
types of fat and fatty acid coatings were experimentally utilized. These did not prove to be
efficient. Lipid coatings that protected MET from ruminal degradation did not release much
MET into the small intestine for absorption (Schwab and Ordway, 2003). Mineral matrices were
also researched. Some methods did not prove to be effective or were expensive to produce
(Graulet et al., 2005).
In a study by Rossi et al. (2003), hydrogenated fatty acids, calcium soaps, ethyl-cellulose,
and pH sensitive polymers were all tested as protective coating methods. The pH polymer
showed the most protection in this study. The ethyl-cellulose coating did reduce the nitrogen
that was released in the rumen. However, it did not release as much MET in the small intestine
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as the pH-sensitive polymer. According to research of Koenig et al. (2001), many types of
coatings show a negative correlation between increased rumen protection and bioavailability of
MET in the small intestine. The pH sensitive polymer has thus far had the most positive results
as far as providing protection from rumen microbes without decreasing systemic bioavailability.
Smartamine (Adisseo, Inc., Antony, France) uses a pH sensitive polymer to protect MET
(Schwab et al., 2003). Seventy-five percent of Smartamine is a DL-MET mixture. It is
currently a popular product due to its ability to adequately supply MET to the small intestine.
Methionine analogs and precursors have also been studied. These increase the bioavailable
MET by allowing the analog to pass through the rumen undegraded where it can then be
synthesized into MET and be utilized by the cow (Koenig et al., 1999; Graulet et al., 2005). 2hydroxy-4-methylthiobutanoic acid (HMB) is a MET analog. The α-amino group of the MET
is replaced with a hydroxyl group. This is designed to protect the HMB from rumen microbes.
HMB can also be esterified to isopropyl ester of the 2-hydroxy-4-(methylthio)-butanoic acid
(HMBi). Metasmart (Adisseo, Inc., Antony, France) is an HMBi product that is relatively
popular in the market. This product contains 57% HMBi. From the HMBi 78% can be
converted into MET (Graulet et al., 2005). Methionine analogs and precursors have had mixed
results and have often had low overall bioavailability (Belasco 1972; Koenig et al., 1999; Graulet
et al., 2005).
Attaching chemical tails to protect MET from microbial degradation has also been
researched in some detail (Wallace et al., 1993; Baxter et al., 2001). This has proven effective
but has often been cost prohibitive. It is therefore not currently used for dietary supplementation.
N-acetyl-L-Met (NALM) has had little research, and little is known about its bioavailability.
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The comparison of NALM to current commercial products is needed to verify relative
effectiveness of various products.

D, L isomers
There are two naturally occurring isomers of MET. These are the D and L isomers. Rumen
protected MET typically contains a mixture of these two isomers. However, D-MET must be
converted into L-MET before it can be utilized. This process is highly inefficient (Baker et al.,
1994). The conversion of D-MET to L-MET means that the D isomer is metabolized more
slowly, and so it accumulates in the plasma (Patton et al., 2015). The research is also unclear as
to how much of the D isomer is actually converted into the L isomer. Furthermore, some
research has shown that increasing the percent of L-MET in a supplement improves hepatic lipid
metabolism in both calves as well as lactating cows (Osorio et al., 2013).
HMB
2- hydroxy-4-methylthiobutanoic acid (HMB) is not actually a rumen protected source of

MET. It is an analog that must be absorbed and then metabolized into MET (Koenig et al.,
1999). The body tissues oxidize HMB into 2-keto-4-(Methylthio)-butanoic acid. The L-alphahydroxy acid oxidase and D-hydroxy acid oxidase enzymes are responsible for this conversion.
It is then transaminated into MET (Graulet et al., 2005). Methionine synthesis from HMB
occurs most actively in the liver, kidneys, rumen, and small intestine of growing lambs (Wester
et al., 2000).
When compared to free MET, HMB effectively delivers MET to the cow instead of rumen
microbes. In studies by Belasco (1972), a batch culture was used to compare the analog with
MET. After 4 hours, 91% of the analog remained while only 55% of MET was still present.
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However, the ruminal protection of HMB is not as effective as many other forms of rumen
protected MET. Koenig et al. (1999) found that about 50% of HMB bypassed the rumen. Once
in the small intestine, it was then absorbed and converted into MET. Although 50% bypasses
the rumen, there are further losses during the conversion from HMB to MET. Serum
concentrations of MET peaked 6 hours post dosing with HMB (Koenig et al., 1999).
HMBi
Isopropyl ester of the 2-hydroxy-4-(methylthio)-butanoic acid (HMBi) has been shown to be
more effective at ruminal protection than HMB. It also stimulates rumen microbes, although the
mechanism is not yet known (Chen et al., 2011). HMBi has also been shown to increase plasma
MET concentrations more than HMB (Ordway et al., 2009). Several studies have been
conducted to show the method of ruminal protection and subsequent absorption of HMBi. There
are many conflicting views. The current consensus is that much of it is absorbed across the
rumen wall. This protects it at least in part from rumen degradation. There is also evidence that
some HMBi makes it to the small intestine where it is absorbed. In a study by Graulet et al.
(2005), the products of HMBi metabolism were tracked to determine how quickly it was broken
down and absorbed. They determined that the HMBi was absorbed rapidly across the rumen
wall and then hydrolyzed into HMB and isopropyl alcohol. HMB is then converted into MET
by tissues of the cow and isopropyl alcohol is converted into acetone by the liver (Wester et al.,
2000). In a study by Graulet et al. (2005), isopropyl alcohol increased in the plasma during the
first 2 hours after HMBi supplementation. It was then slowly but steadily cleared by the liver.
There was also a rapid increase in acetone concentrations. Both of these metabolites returned to
normal plasma concentrations within 40-46 hours after supplementation. HMB was detectable
within the blood as early as 10 minutes following supplementation with HMBi. It then peaked
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an hour later. HMBi was never detected in the peripheral blood during this study. This may
indicate that it was absorbed across the rumen wall and quickly hydrolyzed into HMB.
Methionine concentrations in plasma increased during the 3 hours after HMBi supplementation.
It then decreased back to basal concentrations within 48 hours. When compared with normal
MET kinetics, it was determined that HMBi was absorbed across the rumen wall and then
converted to MET. The ability for HMBi to be absorbed from the rumen is likely due to
lipophilic properties. It is not yet known if HMBi is hydrolyzed within the digestive tract, in the
digestive wall, or in the liver. Ultimately, 50% of HMBi was shown to bypass the rumen and
therefore avoid microbial degradation (Graulet et al., 2005). In a study by Noftsger et al. (2005),
only 2.3% of HMBi escaped from the rumen and was detectable in the omasum. But, significant
absorption from the rumen would have left a very low concentration for passage. Furthermore,
the group treated with HMBi in this study had higher milk protein. It was reasoned that the
increase in milk protein would have been due to ruminal absorption of HMBi.
Smartamine
Because of its size and weight, Smartamine moves with the small, solid particles through the
rumen. A study by Schwab and Ordway (2003) showed that as much as 90% of Smartamine
bypassed the rumen into the abomasum. When the pH becomes more acidic in the abomasum,
the MET is released from its capsule. The majority of it is then absorbed from the jejuno-ileal
area in the small intestine (Graulet et al., 2005). The amount of Smartamine that is available
varies somewhat. The availability of Smartamine is generally around 80%. Robert and Williams
(1997) found that it ranged between 75 and 97%.
In a study by Graulet et al. (2005), HMBi and Smartamine were compared to see the
difference in bioavailability and effects of these two supplementation methods. The MET
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availability of HMBi was estimated to be 48.3 ± 2.05%. The kinetics of absorption seen in this
trial suggested that HMBi was absorbed across the rumen wall. Methionine concentrations in
blood peaked after 4 h and held steady for 4 more h. It then decreased steadily and returned to
basal concentrations within 30 h after supplementation. For Smartamine, the MET availability
was estimated to be 74.4 ± 2.15%. Methionine concentration did not increase in the blood until
10 h after supplementation. It then increased rapidly for 2 h and remained steady for 16 h. The
height of the peak concentration did not differ between treatments, but the area under the curve
was 1.87 times greater for HMBi (Graulet et al., 2005).
NALM
Little research has been done on acetylated MET. The acetyl group that is attached to the
MET prevents deamination by rumen microbes (Wallace, 1992). Once it bypasses the rumen
and enters the small intestine, the AA and acetyl group are separated by an enzyme called
aminoacylase 1 (Baxter et al., 2001). Hydrolysis of the acetylated MET allows its absorption by
the small intestine.
Liver Metabolism
Much research has been done to determine AA metabolism in the liver. Evidence shows
that the liver may use significant amounts of AA (Patton et al., 2010). It extracts AA from the
blood once the needs of the mammary gland have been met. High concentrations of MET may
constrict the blood flow to the mammary gland (Patton et al., 2010). Methionine is used for
many different processes in the liver. It is used as a methyl donor for choline synthesis and
therefore helps in the formation of very low-density lipoproteins (VLDL) (Sharma et al., 1988).
In a study by Osorio et al. (2013), MET seems to alleviate the stress of fatty liver and ketosis.
When in a negative energy balance, dairy cows mobilize adipose tissue to supply energy. The
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liver becomes overloaded with these long-chain fatty acids (LCFA). The incomplete oxidation
of these fatty acids results in the formation of ketone bodies. Supplementation with MET
decreases the incidence of ketosis by preventing the accumulation of triacylglycerides (Osorio et
al., 2013; White 2015).
Isopropyl alcohol increased quickly in plasma after HMBi supplementation. It is then
cleared by the liver where it is converted it into acetone (Graulet et al., 2005). The body can then
use acetone for hepatic gluconeogenesis or it can be utilized in the milk. Acetone can be
returned to the rumen via blood capillaries in the rumen wall. It may also be secreted back into
the rumen via saliva. The rumen environment allows it to be reduced back into isopropyl
alcohol. This can create a metabolic cycle that favors the transfer of reducing hydrogens from
the rumen to the liver (Graulet et al., 2005).
Utilization
Methionine is the most limiting EAA for milk protein synthesis. Feedstuffs do not provide
adequate MET in the diet. High producing cows may require as much as 50 to 60 g of
supplemental MET per day (Koenig et al., 2001). In studies that have researched the effects of
rumen protected MET, results have been inconsistent. According to Patton et al. (2010) milk
protein percentage and milk fat percentage seems to have increased for rumen protected MET
diets in most studies, but some studies showed no result. Studies have seen an increase of milk
fat yield while others have found a decrease in milk fat yield (Patton et al., 2010).
Comparing different supplementation strategies can be difficult because of differences in
protection methods. Ration formulations also vary from one study to the next. There have been
many inconsistencies in research results for rumen protected MET. Many of these could
possibly be attributed to study ration variables. It is also important to note that stage of lactation,
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breed, and health status may affect MET utilization. Therefore, it is important to note that the
source of MET and its availability is an important factor in affecting production parameters.

DMI
With MET supplementation, DMI has been shown in some studies to increase and in others
to remain the same (Patton et al., 2010). The base diets fed vary so widely, that these
discrepancies are often attributed to diet differences. In a study by Chen et al. (2011),
Smartamine and HMBi were compared. In this study, the LYS:MET ratio was 3:1. There were
not any DMI effects seen for either treatment when compared with a positive 0 g dose diet.
There were also not any differences in BW gain.
Smartamine and Metasmart –an HMB product- were compared in a study by Osorio et al.
(2013), and it was found that cows given MET supplements had greater DMI postpartum and
lower BCS than cows that were not given supplementation. There were not significant
differences between the two products. Mepron is a DL-MET that is protected by ethylcellulose
and has been shown to decrease DMI when compared to Smartamine (Patton et al., 2010).
Milk
In a meta-analysis done by Patton et al. (2010), cows fed alfalfa-based diets while being
supplemented with MET tended to have a greater increase in milk. Diets that were high in
energy resulted in less changes in milk protein percentage between treatments. There are also
differences in the protected MET products that were used in the studies. The varying
bioavailability of these products would explain some of the differences in results. Giallongo et al
(2016) also hypothesized that the mixed reports on milk fat content could also be as a result
MET being used to donate methyl groups and in its use for choline synthesis. Osorio et al.
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(2013) discovered that the cows that were fed MET had an increase in milk yield, milk protein
percentage, energy corrected milk, and milk fat yield despite having a lower BCS than 0 g dose
cows.
When comparing Metasmart and Smartamine, Ordway et al. (2009) discovered that milk
conversion from DMI and the ratio of feed nitrogen that became milk nitrogen was lower for
Metasmart. It was hypothesized that this was due to the fact that Metasmart must be converted
from HMBi into MET before it can be utilized. However, HMBi increased energy-corrected
milk and milk protein content. It was hypothesized that this may be due to an increase in
microbial protein synthesis. Both MET supplemented diets and the positive 0 g dose diet
increased milk fat and true protein. Nitrogen efficiency was increased the most in the diet that
was supplemented with Smartamine. Cows supplemented with Smartamine had higher plasma
AA and milk protein. No milk yield differences were observed between HMBi and Smartamine
when the two MET sources were compared by Chen et al. (2011). When compared with
Smartamine, Mepron increased milk production according to Patton et al. (2010). Some studies
have shown that HMB increases milk and milk fat yields, but no increases in milk protein
concentration have been observed (Ordway et al., 2009).
Immunity
In a study by Osorio et al. (2013), the immune capacity increased with MET
supplementation. The lymphocytes seem to have a MET requirement for proliferation. This
was measured by the amounts of blood neutrophil phagocytosis that occurred. So, it should be
understood that MET that is used for other processes in the body will not be available for use in
milk fat or milk protein synthesis.
Lysine

20
Lysine, like other AA has many uses in the body. Similar to MET, it is necessary for
growth, and milk protein synthesis. It is also used for repairing and maintaining tissues. Some
research shows that it is necessary for gestation. Lysine is also used to make carnitine. Fat is
transported into cells by carnitine (Evans et al., 2015). The NRC (2001) recommends that LYS
be included in the diet of dairy cattle at a 7.2% of MP.
LYS Coating
There is limited information available on the LYS products and their respective
availabilities (Evans et al., 2015). This is partially due to the fact that LYS has proven more
difficult to coat and protect than MET. Lysine is highly water soluble (Watanabe et al., 2003).
The positive charge on LYS may make it more reactive with coatings made of fat. Even when
coated in the same manner as MET, it has comparatively higher rates of ruminal degradation
(Rossi et al., 2003). Protecting LYS from rumen degradation is vital, as little more than 3%
passes through into the lower digestive tract (Robinson et al., 2006). Amos and Evans (1978)
found that only 5% of L-Lysine-HCl bypassed the rumen. The most common method of LYS
protection is to coat it with lipid. Several different fatty acid combinations have been used over
the years. Current lipid coatings appear to protect LYS from ruminal degradation. Lipid
coatings that use saturated, long chain fatty acids also raise the melting temperature and increase
the shelf life by preventing auto-oxidation (Sakkers et al., 2013). This makes it easier to store
and transport. It is hypothesized that this method of protection is also the reason that LYS is not
sufficiently released into the intestine and, therefore, is not absorbed well (Wu et al., 2012).
Some research has suggested that acetylating the N terminus of LYS would be an effective
method of protection. Microbes in the rumen break proteins and amino acids down with the
enzyme aminopeptidase (Wallace et al., 1993). This means that blocking access to the amine
group restricts the extent of rumen degradation that can occur. Although rumen bypass
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appeared to be sufficient in nutrition trials, the high cost of production has prevented acetylated
LYS from entering the market (Wallace et al., 1993).
Elwakeel et al. (2015) tested hydroxymethyl LYS in sheep. Hydroxymethyl LYS is created
by reacting Lysine-HCl with formaldehyde in a solution of calcium hydroxide. This study
showed that hydroxymethyl LYS was well protected from ruminal degradation. However, it also
inhibited ruminal microbes to the extent that the overall results were ineffective (Elwakeel et al.,
2015).
Forms and availability
Lysine is present in fair amounts in many animal by-products, but plants are not a good
source. Lysine is typically low in diets that are high in corn-based ingredients. As with other
amino acids, LYS that is available in the diet is often degraded and then utilized by rumen
microorganisms (Evans et al., 2015). For this reason, supplements have been created that
ruminally protect LYS. This allows farmers to supply cows with adequate amounts of LYS
(Evans et al., 2015). In a study by Rossi et al. (2003), several types of protection were
compared. Lysine that was protected using calcium soaps were degraded more than those that
were protected using triglycerides. Another study tested the effects of using different
concentrations of oleic acid in the lipid matrix (Wu et al., 2012). The LYS was protected with a
hydrogenated fat coating that had either 2% or 4% oleic acid. The results of this study indicated
that increasing the percentage of oleic acid in the coating decreased ruminal bypass of the
product. Increasing the percent of LYS present in the product also decreased how much was
able to bypass the rumen.
It has proven difficult to protect LYS from microbes and yet maintain its bioavailability for
the cow. This AA has been shown to be sensitive to Maillard reactions. Furthermore, LYS
does not appear to become highly available in the intestine when it is protected with lipids
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(Sakkers et al., 2013). Watanabe et al. (2003) conducted a study using a LYS product that was
protected with a coat of dehydrogenated tallow. The AA was tested in a solution that simulated
rumen conditions and then in a solution that simulated abomasal conditions. In this study, 75%
of LYS remained stable for 24 hours in solution with a pH similar to that of a typical rumen.
However, only 2% was released in the solution with a pH similar to that of the abomasum. In
the aforementioned study by Wu et al. (2012), the bioavailability of LYS protected by
hydrogenated fats in the small intestine was also tested. The hypothesis was that polyunsaturated
fatty acids would improve the intestinal digestibility and therefore bioavailability of the LYS. It
was discovered, however, that there was no significant increase of intestinal digestibility when
higher concentration of oleic acid was used to protect LYS. This, combined with the decreased
rumen bypass rate showed that increasing oleic acid was not effective.
Wallace et al. (1993) compared two acetylated products with unmodified peptides in order
to see the difference in rumen bypass rate. This study found that acetylated LYS (N-ɛ-methionyl
LYS) and acetylated MET were more stable than the unacetylated peptides. This increased the
proportion of amino acid that passed through the rumen into the lower digestive tract.
Lactation
A study by Giallongo et al. (2016) tested a diet with several different amounts of AA
supplementation. The basal diet was deficient in MP. In the cows that were only supplemented
with LYS, there was an increase in milk protein yield and plasma glucose concentration. When
adequate amounts of MET and histidine were also supplied with LYS supplementation, milk fat
yield, ECM and feed efficiency were also increased.
DMI
Dry matter intake was decreased for the LYS supplemented diet in the study by Giallongo
et. al (2016). In another study, however, no milk production or composition effects were seen
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when the diet was supplemented with LYS (Paz et al., 2013). Effects vary from study to study
based on diets, stage of lactation, and many other factors.

Cobalt as a marker
Cobalt leaves the rumen with the liquid portion of the diet. Since NALL and NALM are
quickly dissolved in liquid, they also pass through the rumen with the rest of the liquid. Cobalt
can be used effectively to determine the rumen bypass rate of NALL and NALM because it
leaves the rumen at approximately the same rate as the rumen protected AA (Sakkers et al.,
2013).
Conclusion
Balancing AA in the diet of dairy cows is necessary in order to maintain milk production
and milk protein synthesis. There have been many methods for protecting AA from ruminal
degradation over the last few decades. The improved protection allowed for more AA to become
available for absorption from the small intestine. The AA must be released from the coating
method before it can be absorbed. Results for overall bioavailability have been variable;
especially for LYS. It is believed that attaching chemical tails to the α-amino group of AA
would improve overall bioavailability. Three experiments were designed to test the overall
availability of one rumen protected MET product and two rumen protected LYS products.
Rumen bypass and duodenal appearance were measured. Blood AA concentration was
monitored so that blood AUC could be calculated. Milk yield, milk protein, milk fat, and DMI
were measured. It was hypothesized that NALM would protect the MET from ruminal
degradation while allowing for release in the small intestine. It was also hypothesized that the
extra MET would increase milk protein synthesis. The first experiment with NALL tested two
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doses of ƐNALL. It was hypothesized that the chemical tail would provide protection in the
rumen and be cleaved from the LYS in the small intestine. Milk protein synthesis and milk yield
was hypothesized to increase in response to LYS supplementation. The second experiment with
NALL compared ƐNALL and diNALL. It was hypothesized that the two NALL products
would have similar bioavailability and production effects. These experiments were designed to
test the ruminal protection and intestinal digestibility of NALM and NALL, as well as the
effects these products have on milk production.
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CHAPTER 3
METHIONINE
Ruminal Protection and Intestinal Availability of Rumen-Protected Methionine in Lactating
Dairy Cows

ABSTRACT

Rumen protected Methionine (MET) is critical for milk protein synthesis in dairy cows. Nacetyl-L-methionine (NALM) is a MET derivative that consists of L-MET protected with an
acetyl group that is attached to the α-amino group. The objective of this study was to quantify
the gastrointestinal availability of NALM by measuring ruminal escape and intestinal
appearance. The experiment was designed as a 3 × 3 Latin square using 3 lactating Holstein
cows that had been fitted with cannulas in the rumen and duodenum. Each cow was fed twice
daily with a diet that consisted of alfalfa hay, corn silage, steam-flaked corn, cottonseed, canola
meal, soybean meal, shredded beet pulp, and a vitamin and mineral mix. The cows were fed this
diet for 2 weeks leading up to the experiment so that the rumen microbes had time to adapt.
Each period consisted of 10 d of adaptation followed by 2 d of sampling. A dose of 0 g
(control), 30, or 60 g of NALM was placed under the rumen mat at the time of feeding every day
during adaptation and hour 0 of the sampling period. On the first day of sampling, a liquid
marker (Co-EDTA) was also administered as a bolus dose at the time of NALM administration.
Blood, ruminal, and duodenal samples were then taken at hours 0, 1, 3, 6, 9, 12, and 24 after
administration of the NALM and liquid marker. A nonlinear regression model was used to
determine fractional rate constants for the passage of the liquid marker and the disappearance of

26
NALM from the rumen. There was no difference between treatments for liquid passage rate or
ruminal NALM passage rate. Ruminal escape as a percentage of the dose was numerically
higher for the 30 g dose (69.1%) than for the 60 g dose (46.2%), but no statistical differences
were found (P = 0.44). Duodenal NALM appearance as a percentage of dose did not differ (P =
0.21) between the 30 g dose (2.16%) and the 60 g dose (3.40%). Dietary treatments did not
affect rumen pH or VFA production. In conclusion, overall results suggest that NALM was
effectively protected again microbial degradation in the rumen and was then extensively digested
post-ruminally.
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INTRODUCTION

Protein is an important nutrient for dairy cows. It is necessary to balance rumen degradable
protein (RDP) and rumen undegradable protein (RUP) such that the microbes are supplied with
protein to grow while the cow still receives sufficient for systemic needs (Weiss et al., 2002).
Supplying sufficient CP is not always adequate to meet production needs. Specific AA are
necessary in the diet (Schwab et al., 2010). Amino acids are utilized for many different purposes
in the body, including tissue growth, milk proteins, and enzymes. Milk protein is reduced if
insufficient AA are present in the diet (Schwab et al., 2010; Lobley et al.,1992). It is generally
accepted that the AA that is limited most frequently in regards to milk protein synthesis in dairy
cows is MET (Schwab et al., 2003; Weiss et al., 2002). In order to ensure that the dietary
requirement of this AA is achieved, many methods have been developed to protect it from
microbial degradation so that it may bypass the rumen and be absorbed from the small intestine
of the cow (Graulet et al., 2005; Rossi et al., 2003; Koenig et al, 2001). Along with improving
milk components, feeding bypass AA also increases the efficiency of nitrogen utilization and
therefore decreases the deleterious effects nitrogen can have on the environment (Ordway et al.,
2009). The benefits of feeding rumen protected AA depends on the efficacy of the individual
products to supply MET to the cow via absorption from the small intestine. The NALM product
is a MET derivative where the MET is protected from rumen degradation by an acetyl group
that is attached to the α-amino group of the AA (Wallace et al., 1992). The NALM product was
tested in vitro by Wallace et al. (1992). After 48 h, 67% of the NALM was still present in the
protected form. The ability of NALM to bypass the rumen in vivo needed to be determined. The
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present study compared the extent to which NALM provided protection from rumen degradation
and yet became available for absorption from the small intestine.
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MATERIALS AND METHODS

Animals and Diets

Three lactating Holstein dairy cows (second-lactation cows; 631 ± 5.9 kg BW) with ruminal
(10 cm diameter, Bar Diamond, Parma, ID) and duodenal T-type (Bar Diamond, Parma, ID;
placed 10 cm distal to the pylorus) cannulas were used in an experiment of 3 X 3 Latin square
design. Cows were adapted to the basal diet for 2 weeks before beginning the experiment. Each
of the 3 periods consisted of 10 d adaptation and 48 h sampling.
All care and procedures were approved by the Institutional Animal Care and Use Committee of
Utah State University. Cows were housed in individual tie stalls. Each stall had a rubber mat
that was bedded daily with straw. Clean water was accessible at all times. Cows were milked
twice daily at 0400 and 1530 h. The DIM for the three cows averaged 22 days at the beginning
of the trial and averaged 98 days by the end.
The TMR was mixed daily and was composed of alfalfa hay, corn silage, straw, steamflaked corn, cottonseed, soybean meal, canola meal and a vitamin and mineral mix (Table 1).
Each cow was fed in her individual bunk twice each day at 0600 and 01600 h throughout the
experiment. Enough TMR was given so that approximately 10% orts were left each morning.
Cows were supplemented with 0, 30, or 60g NALM each day of the adaptation period and hour
0 of the sampling period. Supplements were placed through the rumen cannula, beneath the
rumen mat 15 minutes after the morning feeding.
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Table 1. Ingredients and chemical composition of the experimental diets with varying does of Nacetyl-L-methionine supplemented to early lactation Holstein dairy cows.
Diet
Item
0 g/d NALM
30 g/d NALM
60 g/d NALM
Ingredient, % of DM
Alfalfa Hay
29.35
29.31
29.28
Corn Silage
27.08
27.04
27.01
Wheat Straw
3.22
3.22
3.21
Corn, steam-flaked
12.31
12.29
12.28
Cottonseed, whole
5.30
5.30
5.29
Canola meal
6.91
6.90
6.89
Soybean meal
6.91
6.90
6.89
Beet pulp, shredded
5.11
5.11
5.10
Vitamin and mineral mix
2.67
2.67
2.66
Sodium bicarbonate
1.14
1.13
1.13
NALM
0
0.12
0.25
Chemical composition, % of DM
DM, %
96.7
96.7
96.7
OM
88
88
88
CP
15.8
15.8
15.8
NDF
38.5
38.5
38.5
ADF
25.7
25.7
25.7
Ether Extract
1.5
1.5
1.5
LYS, %MP
6.78
6.74
6.70
MET, %MP
1.92
2.29
2.67
LYS:MET
3.54
2.94
2.51

Sampling

Each period consisted of 10 days of adaptation followed by 48 h of sampling. The amount
of TMR fed and refusals were recorded every day of the entire trial. Samples of the TMR and
of individual refusal were taken from day 5 of adaptation through day 2 of sampling. These were
dried and ground. Body weights for each cow were taken on days 9 and 10 of each adaptation
period. A liquid marker of Co-EDTA was given ruminally at the same time as the NALM was
administered (0 h of sampling) at the start of the sampling periods. This marker was prepared
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according to instructions given in Uden et al. (1980) and was then dissolved in 500 mL of
distilled water so that each dose contained 3 g of cobalt.
Rumen, duodenal and blood samples were taken at 0, 1, 3, 6, 9 ,12, and 24 h after the cobalt was
given on the first day of sampling. Rumen samples were taken from various parts of the rumen
through the cannula. This was then strained to remove solids and microbes. Samples were then
acidified with 6 M HCl for ammonia analysis, or HPO3 for VFA analysis and frozen (-40ºC).
Duodenal contents (100 ml) were collected and frozen for later analysis. The pH of rumen and
duodenal contents was measured at each sampling. At 48 h, the rumen contents of the cows
were removed and then weighed. The rumen contents of each cow were then placed into the
rumen of the cow that would be the next to receive the corresponding supplementation. This was
intended to expedite the adaptation process for the rumen microbes. A sample was taken and
dried in a 60º C oven until dry to determine dry matter content. Blood was collected from the
coccygeal vein into purple top Vacutainer tubes, centrifuged at 3000 X g for 25 min. Plasma
was removed from the cells and then frozen until analyzed. Blood plasma was also collected for
blood ketone and glucose analysis 0 and 24 h after Co-EDTA administration.
Milk yield was recorded daily from 14 d before the first adaptation until the end of the
experiment. Milk samples were taken a.m. and p.m. of the 2 sampling days and preserved with
potassium dichromate and analyzed for fat, protein, lactose, somatic cell count, and MUN by
Rocky Mountain DHIA lab (Logan, UT).
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Chemical Analysis

All TMR and refusal samples were dried in a 60◦ C oven for 48 h and weighed to determine
DM. They were then ground through a 1-mm screen for analysis. Both NDF and ADF were
analyzed according to standard procedures using an Ankom 2000 Fiber Analyzer (Ankom
Technology, Macedon, NY). These procedures were based upon the research and fiber analysis
work by Van Soest and Robertson (1980). Approximately 0.9-1.0 g from ground sample was
sealed in an Ankom XT4 bag and analyzed for fat content using an XT15 ether extract machine
(Ankom Technology, Macedon, NY). Each sample was extracted for 40 min at 70°C and then
dried at 102°C for 16 hr. Percentage fat was determined as mass lost after extraction and drying.
Rumen and duodenum samples (100 ml) were freeze dried and then ground using a mortar
and pestle. These samples were then sent to CJ CheilJedang Bio (Seoul, South Korea) for MET
and cobalt analyses. Each sample was diluted (X 40 dilution) using deionized water and
vortexed until dissolved. These samples were then sonicated for 20 min. The solution was
centrifuged for 20 minutes at 4000 X g. The supernatant was filtered through a 0.45 µL syringe
filter and then analyzed for NALM concentration using UHPLC (Shimadzu Nexera, Seoul,
South Korea). An additional 0.1 g of each ground sample was dissolved in 4 mL nitric acid, 4
mL water, and 2 mL hydrogen peroxide before being digested by acid assisted microwave
irradiation using an Ethos Easy digestor system (Milestone Srl, Sorisole, Italy) for 30 min at
200° C. These samples were then diluted with 50 mL deionized water and tested for cobalt
concentration with plasma mass spectrometry (ICP-MS, Agilent, Santa Clara, CA).
Each rumen sample was analyzed for NH3-N. First, 2-3 mL of rumen fluid was spun in a
microcentrifuge at 12000 X g for 2 min. 100 µL of the supernatant was then diluted with 400 µL
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of distilled water and vortexed. Twenty µL of the solution was then placed in a microwell. Each
sample was mixed with reagents made of phenol, sodium nitroprusside, sodium hydroxide,
sodium hypochlorite, and ammonium sulfate. The preparation of the reagents and the procedure
of mixing them with the samples was done according to the protocols established by
Weatherburn (1967). After mixing with the reagents, the samples were run in an MRX
microplate reader (Dynatech, Alexandria, VA).
Blood MET was determined using EZ:faast (Phenomenex, Torrance, CA) reagents and
protocol for gas chromatography. Rumen samples were prepared for analysis by centrifugation
at 12000 X g for 10 minutes. The supernatant was analyzed for MET using a Hewlett-Packard
6890 GC (Agilent, Santa Clara, CA) as explained by Eun and Beauchemin (2007).

Calculations and Statistical Analysis

The fractional rate constants for the cobalt marker and the MET were determined by
running nonlinear regression analysis in SAS 9.4. The NALM is soluble in liquid. It dissolves
quickly and is assumed to pass with the liquid portion of the rumen. The fractional rate constant
of NALM was equated to that of the liquid cobalt marker.
The calculations and statistical analysis for fractional rate constants, ruminal disappearance,
duodenal appearance, and duodenal area under the curve (AUC) were run according to the
protocol set in Koenig et al. (2002).
Data for DMI, milk yield, milk protein, milk fat, and blood parameters were run using a
Latin square mixed linear model (PROC MIXED; SAS 9.4). Treatment and period were run as
fixed effects, and cow was run as a random effect.
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RESULTS AND DISCUSSION

No differences were seen in milk yield and composition between treatments (Table 2). This
may have been due in part to the fact that the experimental periods were short. Research into
MET supplementation shows varying results for milk production. In a meta-analysis of MET
trials, Patton et al. (2010) found that milk fat and milk protein increased in response to MET in
some trials but decreased in other trials. The varied response of milk fat may be due to the many
alternate uses of MET in the body (Giallongo et al., 2016). Results for milk yield also varied
between trials. Some trials did not see any differences in milk yield (Osorio et al., 2013; Chen et
al., 2011; Ordway et al., 2009). No decreases in DMI were recorded in response to NALM
treatment (Table 2). This seems to indicate that no feedback mechanisms were triggered by
NALM that would decrease appetite - at least not during the length of this trial. Previous
research observed differing responses of DMI to MET supplementation (Osorio et al., 2013;
Chen et al., 2011).

Table 2. Dry matter intake, body weight, and milk parameters of second lactation dairy cows
fed rumen protected methionine.1
0g
DMI (kg/day)
30.0
Milk Protein
2.8
Milk Fat
3.8
Lactose
4.7
SNF
8.3
SCC
18.2
MUN
14.6
Yield (kg/day)
28.6
BW (kg)
641.6
1
0 g, 30 g, and 60 g of NALM (CJ).

60 g
31.8
2.8
3.5
4.7
8.3
17.8
14.6
28.6
645.6

30 g
31.1
2.8
3.5
4.7
8.3
10.8
14.4
27.3
645.9

SEM
7.36
0.07
0.20
0.08
0.12
8.96
0.66
8.76
21.79

P
0.33
0.42
0.22
0.78
0.18
0.33
0.89
0.28
0.29
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Rumen pH and VFA production did not differ between treatments. There was a trend
for rumen pH to be higher for the 0 g dose than for the NALM treatments (Table 3; P = 0.09).
Although it appears that the NALM was splitting prior to the duodenal sampling site, there was
no significant increase in blood MET AUC between treatments (Table 3; P = 0.43). The AUC
60 g dose was numerically lower than the 30 g dose and the 0 g dose (Table 3; 1610, 2162, and
2361 respectively). This may indicate that the body absorbed and utilized the MET that it
needed. Previous research on AA absorption has indicated that increased supplementation
results in decreased efficiency of absorption of the AA (Vyas et al., 2009). The 60 g dose may
have been high enough that the need for MET was exceeded and the absorption pathways downregulated. This has been seen in previous research on AA absorption (Vyas et al., 2009; Lee et
al., 2015).

Table 3. Ruminal pH, ammonia-N, VFA profiles and blood methionine AUC of second lactation
dairy cows fed a diet with rumen-protected methionine1
0g
6.5

60 g
6.3

30 g
6.3

SEM
0.19

P
0.09

Duodenum pH
2.9
NH3-N, mg/100
7.6
mL
Individual VFA, mol/100 mol
Acetate (A)
1.2

3.0

2.9

0.08

0.37

7.6

7.9

0.84

0.93

1.1

1.1

0.05

0.21

Rumen pH

Propionate (P)

0.2

0.2

0.2

0.03

0.80

Butyrate

0.1

0.1

0.1

0.01

0.36

Valerate

0.01

0.01

0.01

0.002

0.37

Isobutyrate

0.01

0.01

0.01

0.001

0.2

0.01
5.0

0.01
4.7

0.01
4.8

0.001
0.22

0.34
0.03

124.8

117.5

68.8

33.06

0.47

2361

1610

2162

441.9

0.43

Isovalerate
A:P
Blood methionine
Baseline
Blood MET AUC,
µM/L
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1

0 g, 30 g, and 60 g of NALM (CJ).
Liquid passage rate was determined by the concentration of a liquid cobalt marker as

described in Koenig et al. (2002). Treatment did not affect liquid passage rate. Fractional rate
constant of NALM going into the small intestine was not affected by treatment. Ruminal escape
of NALM was numerically higher for the 30 g dose (69.1%) than for the 60 g dose (46.2%), but
no statistical differences were observed (Table 4; P = 0.44). The percentage of NALM that
escaped the rumen was roughly that noted in vitro by Windschitl et al. (1988). Duodenal
appearance was low (2.16%-3.40%) but did not differ significantly between treatments (Table 4;
P = 0.21). These results are relatively consistent with findings from Koenig et al. (2010).
Duodenal appearance of NALM may have appeared low due to the fact that the acid
environment of the abomasum and aminoacylase 1 in the small intestine split the acetyl group
from the MET (Baxter et al. 2001). This allows for MET to be absorbed in the small intestine.
Low duodenal appearance may indicate that the acetyl group of NALM was indeed being
cleaved from the MET prior to the duodenal collection, as intended.

Table 4. Ruminal escape and duodenal appearance of NALM in second lactation dairy cows fed
a diet with rumen-protected methionine1
0g
60 g
30 g
SEM
P
Ruminal
126.9
129.5
127.4
7.43
0.91
volume, L
Ruminal flow
14.0
13.8
13.7
1.75
0.36
rate, L/h
Fractional rate
constants, /h
Liquid
0.113
0.108
0.107
0.016
0.65
NALM
…
0.30
0.13
0.06
0.13
Ruminal
escape, % of
dose

…

46.2

69.1

18.39

0.45

37
Duodenal
NALM, AUC
µg/ml·h

…

145.3

Duodenal
…
3.4
NALM
appearance, %
of dose
1
0 g, 30 g, and 60 g of NALM (CJ).

50.9

9.15

<0.0001

2.2

0.56

0.21

The NALM product provided reasonable protection of MET from ruminal degradation. It
appears to have been split prior to the collection site in the duodenum. Future studies are also
needed to research the effects of NALM on milk production over a longer period of time.

CHAPTER 4
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LYSINE
Ruminal Protection and Intestinal Availability of Rumen-Protected Lysine in Lactating Dairy
Cows

ABSTRACT

Lysine (LYS) is one of the most limiting amino acids for dairy cow production. Rumen
protected LYS is important for milk protein synthesis. Two different rumen protected LYS
derivatives were tested in two consecutive trials. Both ƐN-acetyl-L-Lysine (ƐNALL) and Nα,Ɛacetyl-L-Lysine (diNALL) are protected from rumen degradation with an acetyl group attached
to the α-amino group. The objective of this study was to quantify the gastrointestinal availability
of N-acetyl-L-Lysine (NALL) by measuring ruminal escape and intestinal appearance. Two
experiments were run as a 3 × 3 Latin square using 3 second lactation Holstein cows that had
been fitted with cannulas in the rumen and duodenum. Each period consisted of 10 days of
adaptation followed by 2 days of sampling. During the first experiment, a dose of 0 (0 g dose),
60, or 120 g of ƐNALL was placed under the rumen mat at the time of feeding every day of
adaptation and hour 0 of sampling periods. A dose of 0 (0 g dose), 120 g ƐNALL, or 120 g
diNALL was given similarly during the second experiment. On the first day of sampling, a
liquid marker (Co-EDTA) was also administered as a bolus dose at the time of NALL
administration. Blood, ruminal, and duodenal samples were then taken at hours 0, 1, 3, 6, 9, 12,
and 24 of sampling. A nonlinear regression model was used to determine fractional rate
constants for the passage of the liquid marker and the disappearance of NALL from the rumen.

During experiment 1, there was no difference between treatments for DMI, milk production,
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liquid passage rate and ruminal NALL passage rate. Ruminal escape as a percentage of the dose
was numerically higher for the 120 g dose (32.7%) than for the 60 g dose (27.2%), but no
statistical differences were found (P = 0.54). Duodenal NALL appearance as a percentage of
dose was higher (P < 0.01) for the 60 g dose (2.86%) than for the 120 g dose (1.19%). The
production of acetate, butyrate, propionate, and valerate (Table 3; P < 0.01) was greater for the
supplemented cows than for the 0 g dose cows. There was a trend for isobutyrate to be higher
for the supplemented cows than for the 0 g dose (Table 3; P = 0.06). For experiment 2, no
differences were seen in DMI, milk yield, and milk composition between treatments. There was
a trend (P = 0.08) for ƐNALL to have a higher rumen pH than diNALL. There were no
differences between treatments for fractional rate constants, ruminal escape, or duodenal
appearance. There do not appear to be any significant differences between ƐNALL and
diNALL. Both provided significant protection from rumen degradation.

INTRODUCTION
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It is generally accepted that dairy cows have a need for specific AA rather than a specific
amount of CP. Lysine is an important AA that is used in milk protein synthesis as well as tissue
growth. It is also an important player in fat metabolism due to the fact that it is used to make
carnitine, which is essential for utilization of mobilized fat stores (Evans et. al, 2015). Lysine is
often limited in typical dairy diets, and therefore, must be supplemented (Weiss et al., 2002).
Very little free LYS escapes rumen degradation. As little as 3-5% of LYS supplemented in
the free form or as a salt makes it into the lower digestive tract (Amos and Evans, 1978;
Robinson et. al, 2006). Much research has been done to find a way to protect LYS from
degradation in the rumen (Wallace et al., 1993; Watanabe et al., 2003; Sakkers et al., 2013;
Evans et al., 2015). Methods that have previously worked to ruminally protect MET have proven
inefficient for LYS protection (Rossi et al., 2003). The most common method of protecting LYS
in the rumen is to coat the AA with a lipid complex. Lysine is more reactive than MET and
tends to interact with the lipid matrix and this increased reactivity leads to the LYS remaining
bound to the lipid coating in the lower digestive tract (Wu et. al, 2012).
Studies found that blocking the amine group of AA provides adequate protection in the
rumen while allowing for degradation in the abomasum and small intestine (Wallace et al., 1993;
Baxter et al., 2001). This happens because attaching a chemical tail to the N terminus blocks
rumen microbes from breaking down the AA. Lower pH in the abomasum weakens the bonds
and allows the chemical tail and the AA to be cleaved by aminoacylase (Baxter et al., 2001).
However, the process of chemical modification to protect AA has been cost prohibitive up to this
point in time. But, both the ƐNALL and the diNALL are protected with an acetyl group
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attached to the α-amino group using a more efficient process (Wallace et. al, 1993). The present
study was intended to compare the rumen protection, bioavailability and production effects of
these NALL products in dairy cows.

MATERIALS AND METHODS
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Animals and Diets

Three lactating Holstein dairy cows (second-lactation cows; 735.7±33.3 kg BW for
experiment 1 and 783.2±22.3 kg BW for experiment 2) with ruminal (10 cm diameter, Bar
Diamond, Parma, ID) and duodenal T-type (placed 10 cm distal to the pylorus, Var Diamond,
Parma, ID) cannulas were used in 2 experiments of 3 X 3 Latin square design with 3 periods of
10 d adaptation and 48 h sampling.
All care and procedures were approved by the Institutional Animal Care and Use Committee
of Utah State University. Cows were housed in individual tie stalls. Each stall was bedded daily
with straw. Clean water was accessible at all times. Cows were milked twice daily at 0400 and
1530 h. The average DIM was 207-243 days for experiment 1 and 243 -307 days for experiment
2.
Cows were put in tie stalls and adapted to the diets for a 2-week period before the
experiment began. The TMR was composed of alfalfa hay, alfalfa haylage, corn silage, straw,
steam-flaked corn, high moisture corn, cottonseed, soybean/canola meal, beet pulp and a
vitamin/mineral mix (Table 1). Each morning of the adaptation, cows were given the
supplement under the rumen mat 15 minutes after feeding. Each cow was given the supplement
and the cobalt marker hour 0 of sampling. The treatments were 0g (0 g dose), 60g, or 120g
ƐNALL for experiment 1, and either 0g, 120g ƐNALL, or 120g diNALL for experiment 2.
Each cow was fed in her individual bunk twice each day at 0600 and 01600 h throughout both
experiments. Enough TMR was given so that approximately 10% orts were left each morning.
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Table 1. Ingredients and chemical composition of the experimental diets with varying does of Nacetyl-L-lysine supplemented to early lactation Holstein dairy cows
Diet
Item
0 g/d
60 g/d
120 g/d
120 g/d
ƐNALL
ƐNALL
ƐNALL
diNALL
Ingredient, % of DM
Alfalfa Hay
17
17
17
17
Alfalfa Haylage
14.7
14.7
14.7
14.7
Corn Silage
8.6
8.6
8.6
8.6
Wheat Straw
5.9
5.9
5.9
5.9
Corn, steam-flaked
12.5
12.5
12.5
12.5
High Moisture Corn
9.6
9.6
9.6
9.6
Cottonseed, whole
7.3
7.3
7.3
7.3
Canola meal
4.5
4.5
4.5
4.5
Soybean meal
4.2
4.2
4.2
4.2
Beet pulp, shredded
6.7
6.7
6.7
6.7
Vitamin and mineral mix
1.9
1.9
1.9
1.9
Sodium bicarbonate
0.6
0.6
0.6
0.6
NALL
0
0.2
0.4
0.4
Chemical composition, %
of DM
DM, %
94.7
94.7
94.7
94.7
OM, %
90.3
90.3
90.3
90.3
CP
16.4
16.4
16.4
16.4
NDF
39.6
39.6
39.6
39.6
ADF
24.6
24.6
24.6
24.6
Ether Extract
3.58
3.58
3.58
3.58
LYS, % MP
6.54
9.34
12.14
12.14
MET, % MP
1.85
1.82
1.79
1.79
LYS:MET
3.53
5.13
6.78
6.78

Sampling

Each period consisted of 10 d adaptation followed by 48 h of sampling. The amount of
TMR fed and refusals were recorded every day of the entire trial. Samples of the TMR and of
individual refusal were taken from day 5 of adaptation through day 2 of sampling. These were

dried and ground. Body weights for each cow were taken on days 9 and 10 of each adaptation
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period. A liquid marker of Co-EDTA was given ruminally at the same time as the NALL
supplements (0 h of sampling). This marker was prepared according to instructions given in
Uden et al. (1980) and was then dissolved in 500 mL of distilled water so that each dose
contained 3 g of cobalt.
Rumen, duodenal and blood samples were taken at 0, 1, 3, 6, 9 ,12, and 24 h after the cobalt
and NALL were given on the first day of sampling periods. Rumen samples were taken from
various parts of the rumen through the cannula. This was then strained to remove solids and
microbes. Samples were then acidified with 6 M HCl for ammonia analysis, or HPO3 for VFA
analysis and frozen (-40ºC). Duodenal contents (100 mL) were collected and frozen until
processed for analyses. The pH of rumen and duodenal contents was measured at each sampling.
Blood was collected from the tail vein into purple top Vacutainer tubes, centrifuged at 3000 X g
for 25 min. The plasma was then separated from the cells and frozen until analysis. Blood
serum was also collected for glucose and ketone analysis in red top Vacutainer tubes at 0 h and
24 h after Co-EDTA administration.
Milk yield was recorded daily from 14 d before the first adaptation until the end of the
experimental periods. Milk samples were taken a.m. and p.m. of the 2 sampling days, preserved
with potassium dichromate, and analyzed for percent fat, percent protein, lactose, somatic cell
count, and MUN by Rocky Mountain DHIA (Logan, UT).

Chemical Analysis
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All TMR and refusal samples were dried in a 60◦ C oven for 48 hours and weighed to
determine DM. They were then ground through a 1-mm screen for analysis. NDF and ADF was
analyzed according to standard procedures using an Ankom 2000 Fiber Analyzer (Ankom
Technology, Macedon, NY). These procedures were based upon the research and fiber analysis
work by Van Soest and Robertson (1980). Approximately 0.9-1.0 g from ground sample was
sealed in an Ankom XT4 bag and analyzed for fat content using an XT15 ether extract machine
(Ankom Technology, Macedon, NY). Each sample was extracted for 40 min at 70°C and then
dried at 102°C for 16 hr. Percentage fat was determined as mass lost after extraction and drying.
Rumen and duodenum samples (100 mL) were freeze dried and then ground using a mortar
and pestle. These samples were then sent to CJ CheilJedang Bio (Seoul, South Korea) for LYS
and cobalt analysis. Each sample was diluted (X 40 dilution) using deionized water and vortexed
until dissolved. These samples were then sonicated for 20 minutes. The solution was
centrifuged for 20 minutes at 4000 X g. The supernatant was filtered through a 0.45 µL syringe
filter and then analyzed for NALL concentration using UHPLC (Shimadzu Nexera, Seoul, South
Korea). An additional 0.1 g of each ground sample was dissolved in 4 mL nitric acid, 4 mL
water, and 2 mL hydrogen peroxide before being digested by acid assisted microwave irradiation
using an Ethos Easy digestor system (Milestone Srl, Sorisole, Italy) for 30 minutes at 200° C.
These samples were then diluted with 50 mL deionized water and tested for cobalt concentration
with plasma mass spectrometry (ICP-MS, Agilent, Santa Clara, CA).
Each rumen sample was analyzed for NH3-N. First, 2-3 mL of rumen fluid was spun in a
microcentrifuge at 12000 X g for 2 minutes. 100 µl of the supernatant was then diluted with 400

µL of distilled water and vortexed. 20 µL of the solution was then placed in a microwell. Each
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sample was mixed with reagents made of phenol, sodium nitroprusside, sodium hydroxide,
sodium hypochlorite, and ammonium sulfate. The preparation of the reagents and the procedure
of mixing them with the samples was done according to the protocols established by
Weatherburn (1967). After mixing with the reagents, the samples were run in an MRX
microplate reader (Dynatech, Alexandria, VA).
Blood LYS was determined using EZ:faast (Phenomenex, Torrance, CA) reagents and
protocol for gas chromatography. Rumen samples were prepared for analysis by centrifugation
at 12000 X g for 10 minutes. The supernatant was analyzed for LYS using a Hewlett-Packard
6890 gas chromatograph (Agilent, Santa Clara, CA) as explained by Eun and Beauchemin
(2007).

Calculations and Statistical Analysis

The fractional rate constants for the cobalt marker and for the NALL were determined by
running nonlinear regression analysis in SAS 9.4. The NALL products dissolve quickly in the
rumen fluid. Therefore, the rate of passage from the rumen was assumed to be equal to that of
the liquid marker.
The calculations and statistical analysis for fractional rate constants, ruminal disappearance,
duodenal appearance, and duodenal area under the curve (AUC) were run according to the
protocol set in Koenig et al. (2002).

Data for DMI, milk yield, milk protein, milk fat, and blood parameters were run using a
Latin square mixed linear model (PROC MIXED; SAS 9.4). Treatment and period were run as
fixed effects, and cow was run as a random effect.
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RESULTS AND DISCUSSION

There were no significant differences in DMI and milk yield for experiment 1 (Table 2).
Milk production parameters such as protein and fat were also not altered significantly during
experiment 1 (Table2). Some of this may have been due to the short length of the test period.
The lack of effect on milk protein could also be attributed to the stage of lactation. Dairy cows
are more sensitive to AA supplementation during early lactation when their needs are typically
greater than their intake (Calsamiglia et al., 2010; Lee et al., 2015).

Table 2. Dry matter intake, body weight, and milk parameters of second lactation dairy cows
fed rumen protected lysine1
0g
120 g
60 g
SEM
P
DMI (kg/day)

36.5

36.7

37.0

2.22

0.89

Milk Protein

3.2

3.3

3.2

0.08

0.60

Milk Fat

3.7

3.8

3.9

0.32

0.60

Lactose

4.2

4.3

4.2

0.16

0.47

SNF

8.2

8.4

8.3

0.21

0.48

SCC

201.5

187.3

175.1

55.55

0.74

MUN

13.6

15.0

14.5

0.64

0.12

Yield (kg/day)

27.7

26.8

26.5

6.99

0.43

BW (kg)

740.2

727.5

738.6

15.96

0.09

10

g, 60 g, and 120 g of ƐNALL (CJ Bio).
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During experiment 1, we observed a numerically greater percent of the 120 g dose of NALL
escaped the rumen (Table 4; 32.7%) than the 60 g dose (Table 4; 27.2%). This could be
explained by the greater concentration of NALL in the rumen and a saturation of breakdown
capacity. A greater percent would be expected to escape the rumen microbes. This difference
was not statistically significant.
Blood LYS AUC was greater for the 0 g dose than the supplemented groups during
experiment 1. We observed greater blood LYS AUC for the 120 g dose than for the 60 g dose
(Table 3, P = 0.02). The higher blood LYS AUC for the 0 g dose may indicate that the chemical
tail was not cleaved properly. The dosage of LYS may have been high enough to cause a
downregulation of LYS absorptive pathways, which has been seen in previous research (Vyas et
al., 2009). Acetate, propionate and valerate production was higher (Table 3; P < 0.01) for the
supplemented groups than for the group that was given 0 g NALL. Butyrate production was
significantly higher (Table 3; P < 0.01) for the 120 g dose of ƐNALL than for the 0 g dose. We
noted a trend (Table 3; P = 0.06) for isobutyrate production to be higher in the group
supplemented with 120 g of ƐNALL than for the 0 g dose. The 0 g dose group had a higher
acetate to propionate ratio (Table 3; P < 0.01) than the group supplemented with the 120 g dose.
An increase in VFA production seems to indicate that the ƐNALL that was not protected was
being used by the rumen microbes. Increased VFA production leads to increased energy
available for use by the cow. This increase in VFA production in response to supplementation
may be responsible for the increase in milk production and milk fat seen in other research
(Giallongo et al., 2016). We observed a higher acetate to propionate ratio for the 0 g dose than
for the 60 g or 120 g doses (Table 3; P < 0.01). The lower acetate to propionate ratio coupled

with the overall increase in VFA production for the cows supplemented with LYS means that
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there is more propionate available for gluconeogenesis.

Table 3. Ruminal pH, ammonia-N, VFA profiles, and blood lysine concentration in second
lactation dairy cows fed a diet with rumen-protected lysine1
0g
120 g
60 g
SEM
P
Rumen pH

6.28

6.05

6.20

0.150

0.23

Duodenum pH

2.86

2.88

3.02

0.147

0.71

NH3-N, mg/100 mL

5.60

5.61

5.48

0.608

0.97

Individual VFA, mol/100 mol
Acetate (A)

0.60

0.70

0.67

0.043

<0.01

Propionate (P)

0.19

0.25

0.23

0.027

<0.01

Butyrate

0.13

0.16

0.14

0.015

<0.01

Valerate

0.018

0.022

0.021

0.0017

<0.01

Isobutyrate

0.011

0.012

0.012

0.001

0.06

Isovalerate

0.02

0.02

0.02

0.002

0.21

3.13

2.85

2.99

0.1

<0.01

Baseline

157.3

123.3

134.6

60.78

0.57

Blood LYS AUC,
µM/L

2624

2222

2108

314.3

<0.01

A:P
Blood Lysine

10

g, 60 g, and 120 g of ƐNALL (CJ Bio).

We observed a trend (Table 4; P = 0.07) for the 60 g dose to have a higher duodenal AUC of
NALL than the 120 g dose. A higher percentage of NALL appeared in the duodenum for the 60

g dose than for the 120 g dose (Table 4; P < 0.05). Rumen flow was numerically lower for the
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120 g dose (Table 4; 16.3) than for the 60 g dose (Table 4; 18.9). This slower escape from the
rumen may have allowed enzymes to more completely break down the NALL before it reached
the duodenum. This would result in a lower AUC and duodenal appearance of NALL for the
120 g dose than for the 60 g dose.

Table 4. Ruminal escape and duodenal appearance NALL in second lactation dairy cows fed a
diet with rumen-protected lysine1
0g
120 g
60 g
SEM
P
Ruminal flow
rate, L/h

18.0

16.3

18.9

2.78

0.12

Liquid 0.14

0.13

0.14

0.022

0.91

0.45

0.52

0.066

0.51

Fractional rate
constants, /h

Ruminal …
NALL
Ruminal
escape, % of
dose

…

32.7

27.2

6.9

0.54

Duodenal
NALL, AUC
g/kg●h

…

82.8

88.9

14.6

0.07

Duodenal
NALL
appearance, %
of dose

…

1.2

2.9

0.6

0.01

10

g, 60 g, and 120 g of ƐNALL (CJ Bio).
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For experiment 2, we did not see any differences for DMI, milk yield, milk protein, or milk
fat (Table 5). There was a trend (Table 6; P = 0.08) for cows treated with ƐNALL to have a
higher rumen pH than cows treated with diNALL. The acetate to propionate ratio was greater
(Table 6; p < 0.01) for ƐNALL than for the 0 g dose or diNALL. There were no differences
seen in the blood LYS AUC (Table 6; P = 0.41). The diNALL product had blood LYS AUC
that was numerically lower than the 0 g dose and the ƐNALL. This may indicate that the LYS
was not being absorbed as well as had been anticipated. We also did not observe any significant
differences between treatments for the percentage of LYS that escaped the rumen, duodenal
AUC or duodenal appearance of NALL between the two forms (Table 7).

Table 5. Dry matter intake, body weight, and milk parameters of second lactation dairy cows
fed rumen protected lysine1
0g

ƐNALL

diNALL

SEM

P

DMI (kg/day)

37.7

38.9

37.1

3.28

0.61

Milk Protein

3.21

3.21

3.26

0.091

0.51

Milk Fat

3.75

3.73

3.68

0.252

0.74

Lactose

4.15

4.07

4.13

0.208

0.35

SNF

8.17

8.08

8.21

0.303

0.50

SCC

240.1

267.8

266.1

51.51

0.57

MUN

13.1

13.1

13.3

0.651

0.89

Yield (kg/day)

15.45

15.27

16.01

0.868

0.65

BW (kg)

786.7

786.5

586.5

113.41

0.46

10

g, and 120 g ƐNALL (CJ Bio); 120 g diNALL (CJ Bio).

Table 6. Ruminal pH, ammonia-N, VFA profiles, and blood lysine AUC in second lactation
dairy cows fed a diet with rumen-protected lysine1
0g
ƐNALL
diNALL
SEM
P
Rumen pH

6.23

6.31

6.18

0.120

0.08

Duodenum pH

3.12

3.14

3.20

0.047

0.57

NH3-N, mg/100 mL

5.89

4.69

5.45

0.604

0.28

Individual VFA, mol/100 mol
Acetate (A)

0.63

0.61

0.63

0.052

0.83

Propionate (P)

0.20

0.19

0.21

0.027

0.29

Butyrate

0.13

0.13

0.13

0.014

0.38

Valerate

0.02

0.02

0.02

0.001

0.12

Isobutyrate

0.01

0.01

0.01

0.001

0.51

Isovalerate

0.02

0.02

0.02

0.002

0.19

3.11

3.31

3.16

0.202

0.03

Baseline

171.8

56.6

122.2

50.42

0.30

Blood LYS, AUC,
µM/L

3430

3335

2897

51.23

0.41

A:P
Blood lysine

10

g, and 120 g ƐNALL (CJ Bio); 120 g diNALL (CJ Bio).

During experiment 1, the rumen escape for ƐNALL was 32.7% and 27.2 % for the 120 g
and 60 g doses respectively (Table 4). Rumen escape was 44.2% for ƐNALL and 42.8% for
diNALL during experiment 2 (Table 7). This is much greater than the expected 3% of free
dietary LYS that reaches the small intestine (Robinson et al., 2006). A study by Amos and
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Evans (1978) found that only 5% of L-Lysine-HCl bypassed the rumen. Watanabe et al. (2003)
found that some LYS products provide as much as 75% rumen bypass, but the true amount that
becomes available for absorption in the small intestine varies, and is often quite low. Further
research is needed to determine the overall bioavailability of NALL.

Table 7. Ruminal escape and duodenal appearance NALL in second lactation dairy cows fed a
diet with rumen-protected lysine1
0g
ƐNALL
diNALL
SEM
P
Ruminal
volume, L

140.47

139.64

140.70

0.456

0.25

Ruminal flow
rate, L/h

13.24

20.06

18.82

3.543

0.36

0.09

0.13

0.025

0.32

0.43

0.42

0.115

0.51

Fractional rate
constants, /h
Liquid 0.14
Ruminal …
NALL
Ruminal
escape, % of
dose

…

44.2

42.8

20.8

0.82

Duodenal
NALL, AUC
g/kg●h

…

153.6

175.0

25.0

0.36

2.4

2.1

0.7

0.78

Duodenal NALL …
appearance, % of
dose
10

g, and 120 g ƐNALL (CJ Bio); 120 g diNALL (CJ Bio).

The percentage of NALL that appeared in the duodenum was low for all of the treatments
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for experiment 1 (Table 4) and for experiment 2 (Table 7). According to Baxter et. al (2001), the
low pH of the abomasum allows enzymes to split the acetyl group from the NALL. The low
percentage of appearance may indicate that the acetyl group is being efficiently cleaved from the
amino acid prior to duodenal collection. Further research could test this by testing for the
presence of different end products in the small intestine. Highly degradable NALL would
supply more absorbable LYS in the small intestine.
The increased overall VFA production for NALL seen in experiment 1 would mean better
feed efficiency. However, these same effects were not seen in experiment 2. This may be due to
increased DIM. Previous research by Stockdale et al., (1987) saw decreased VFA response to
treatments as lactation progressed. A decrease in DMI may largely be responsible for the
decreased response to treatments (Friggens et al, 1998). Further research would need to be
undertaken to see if the effects on VFA could be recreated and utilized. Overall, NALL shows
potential to provide rumen protection while allowing degradation into absorbable LYS in the
small intestine. Furthermore, increased VFA production could increase efficiency in dairy cows.

CHAPTER 5
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CONCLUSIONS
The main focus of this study was to observe the ability of the NALM and NALL products to
effectively protect MET and LYS in the rumen and still allow these AA to be released for
absorption in the small intestine. The NALM and NALL were fed along with a typical dairy
diet to measure rumen protection and see effects of supplementation on milk production and
DMI. It was expected that milk protein and milk yield would be affected by the rumen-protected
MET and LYS. It was found that the acetylated MET and LYS were protected from rumen
degradation but appeared to be changed post-ruminally. No negative effects on DMI were
observed for either the NALM or the NALL. Adequate rumen protection of MET was observed
for both treatments of the NALM. The 30 g had a higher percent escape than the 60 g dose.
This indicates that the optimum dosage is closer to the 30 g than the 60 g dosage. Future studies
are needed to determine where the optimum dosage is so that the benefits of supplementation can
be maximized. The NALL product also protected LYS from degradation in the rumen. Neither
NALL product appeared to be better than the other. Testing this dosage against other dosages to
determine the optimum is also necessary for the NALL products. The NALM and both NALL
products had low duodenal appearance. It needs to be determined if this low appearance is due
to the effective cleaving of the acetyl group from the AA. Future studies should test for the
products of this cleavage to see if they are present in the duodenum. Although low duodenal
appearance seems to indicate release of the AA, neither study observed significantly increased
blood concentration of MET or LYS. However, neither of these studies were designed to
specifically evaluate the absorption into the blood. The NALM product had numerically higher
blood concentration of the AA for the lower dosages than the 0 g dose. The absorption of the

AA may have been inhibited if the dosages were too high. A high dose during the adaptation
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period may have caused a down-regulation of absorption pathways. During the first experiment
with NALL, significantly increased VFA production was observed. Adequate rumen protection
and intestinal availability combined with increased VFA production would be beneficial for
dairy herds. Having more VFA availability increases the energy available for use by the cow.
Overall, these studies indicate that NALM and NALL have potential to provide rumen
protection. The effectiveness of releasing the AA in the small intestine requires further research.
Determining the optimum dosages will help to increase the benefit of these products. There also
appears to be potential to increase rumen fermentation products, which is important for
maintaining high milk production in dairy cows.
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